FGF21 mutants and uses thereof

Details for Australian Patent Application No. 2011253868 (hide)

Owner Amgen Inc.

Inventors Belouski, Edward John; Ellison, Murielle Marie; Hamburger, Agnes Eva; Hecht, Randy Ira; Li, Yue-Sheng; Michaels, Mark Leo; Sun, Jeonghoon; Xu, Jing

Agent Shelston IP

Pub. Number AU-A-2011253868

Parent 2009256232

Filing date 7 December 2011

Wipo publication date 12 January 2012

International Classifications

C07K 14/50 (2006.01) Peptides having more than 20 amino acids

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

Event Publications

22 December 2011 Complete Application Filed

12 January 2012 Application Open to Public Inspection

  Published as AU-A-2011253868

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011253869-Mask

2011253867-System and method for establishing and providing access to an online account